Lipid Profile (Total Cholesterol, LDL, HDL, Triglyceride) of Injection Contraceptive Acceptors in Semarang
DOI:
https://doi.org/10.26911/thejmch.2021.06.05.12Abstract
Background: Hormonal injectable contraceptives are the most common choice taken by women. The 3-month injection of contraception is DMPA, one of the most effective contraceptive methods currently used. Using injectable contraceptives, especially DMPA, influences fat metabolism, especially lipoproteins. Changes in fat metabolism cause disturbances in the balance of blood fat fractions (fluctuation of HDL, LDL and total cholesterol levels) due to hormonal influences.
Subjects and Method: Descriptive with an observational design study. Seventy-three women accepted injection contraceptive three months with a usage period of more than three years recorded in the Tlogosari Kulon Community Health Center. They were selected based on sample criteria, including inclusion criteria and exclusion criteria, where these criteria determine whether or not the sample can be used. The dependent was lipid profile (cholesterol, trigliceryd, LDL, HDL). The independent variables was contraceptive injections three months. There are seventy-three respondents.
Results: The respondents in this study had 3-month injection contraceptive use of were less than the same as six years of use, namely 41 people, while for use more than the same as seven years there were 32 people and show that most of the research respondents had a lipid profile that was still within normal limits. For the cholesterol levels, 23% is normal, and 76% is abnormal, Trigliceryd level 66% is normal, and 34 % is abnormal. LDL levels 100% is normal, and for the HDL levels, 63% is normal, and 37% is abnormal.
Conclusion: Most of the lipid profiles of respondents were normal. However, on cholesterol levels, respondents had more abnormal levels than normal, but for other lipid profiles (Trigliceryd, LDL, HDL), most respondents had normal levels.
Keywords:
lipid profile, injection contraception, DMPAReferences
Al-Youzbaki WB (2011). C-reactive protein and lipid profile among depot-medroxyprogesterone acetate injections users. Ann Coll Med Mosul. 37(1): 48–56. DOI: 10.33899/mmed.2011.34639.
Yadav BK, Gupta RK, Gyawali P, Shrestha R, Poudel B, Sigdel M, Jha B (2011). Effects of long-term use of depomedroxyprogesterone acetate on lipid metabolism in Nepalese women. Korean J Lab Med. 31(2): 95-7. doi: 10.3343/kjlm.2011.31.2.95.
Daoud E, Scheede-Bergdahl C, Bergdahl, A (2014). Effects of dietary macronutrients on plasma lipid levels and the consequence for cardiovascular disease. J Cardiovasc Dev Dis. 1(3): 201-213. DOI: https://doi.org/10.3390/jcdd1030201
Menazza, S. and Murphy, E (2016). The expanding complexity of estrogen receptor signalling in the cardiovascular system. Circ Res. 118(6): 994-1007. DOI: 10.1161/CIRCRESAHA.115.305376.
Murray RK (2014). Biokimia Harper Edisi 27. Igarss 2014.
Novalia S (2015). Kontrasepsi Hormonal Suntik Depo Medroxyprogesterone Acetate (DMPA) sebagai Salah Satu Penyebab Kenaikan Berat Badan. Fakultas Kedokteran Universitas Lampung, 4(7): 67–72. Retrieved from: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1450/1285.
Palmisano BT, Zhu L, Eckel RH, Stafford JM (208). Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism. 15(2018): 45-55. DOI: 10.1016/j.molmet.2018.05.008.
Prawirohardjo S (2016). Ilmu Kebidanan Sarwono Prawirohardjo. Edisi Ke-4. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo.
Prihati DR, Yeni MNW, Nikmah UN (2019). Gambaran akseptor sekaitan dengan kontrasepsi suntik di Klaten. Jurnal Kebidanan dan Kesehatan Tradisional. 4(1): 6–11. doi: 10.37341/jkkt.v4i1.93.
Rahayu T, Wijanarko N (2017). Efek samping akseptor KB suntik depo medroksi progesterone acetat (dmpa) setelah 2 tahun pemakaian. Jurnal Kesehatan Samodra Ilmu. 8(1): 32-38.Retrieved from: https://media.neliti.com/media/publications/137838-ID-efek-samping-akseptor-kb-suntik-depomed.pdf
Rohmatin (2015). Hubungan antara umur dan lama penggunaan terhadap keluhan kesehatan pada wanita usia subur pengguna alat kontrasepsi hormonal di Pulau Jawa Tahun 2012. Statewide Agricultural Land Use Baseline 2015. Retrieved from: https://repository.uinj-kt.ac.id/dspace/bitstream/123456789/29639/1/Naila%20Rohmatinfkik.pdf
Sufa B, Abebe G, Cheneke W (2019). Dyslipidemia and associated factors among women using hormonal contraceptives in Harar town, Eastern Ethiopia. BMC Research Notes. 120 (2019). doi: 10.1186/s1310401941489.
Wahyuni ES (2017). Kontrasepsi Hormonal Progesteron.
Wulandari PC, Surati S (2019). Gambaran kadar kolesterol pada akseptor kontrasepsi suntik. Jaringan Laboratorium Medis. 1(2): 59. doi: 10.31983/jlm.v1i2.5448.
Utami NW, Herawati T, Saragih L (2010). Lama pemakaian alat kontrasepsi hormonal suntik DMPA dan gangguan kardiovaskuler. Retrieved from: https://www.scribd.com/document/513065652/6a842530
